These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 23085605

  • 21. A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner.
    Jia YY, Tan WJ, Duan FF, Pan ZM, Chen X, Yin YL, Jiao XA.
    Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
    [Abstract] [Full Text] [Related]

  • 22. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):584-91. PubMed ID: 18051710
    [Abstract] [Full Text] [Related]

  • 23. MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model.
    Sin JI.
    Vaccine; 2011 May 31; 29(24):4125-31. PubMed ID: 21496466
    [Abstract] [Full Text] [Related]

  • 24. Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer.
    Ajorloo M, Alamdary A, Soleimanjahi H, El Boulani A, Khanizadeh S, Nikoo HR.
    Microb Pathog; 2019 Jul 31; 132():20-25. PubMed ID: 31004722
    [Abstract] [Full Text] [Related]

  • 25. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM.
    Vaccine; 2006 Apr 05; 24(15):2880-93. PubMed ID: 16472545
    [Abstract] [Full Text] [Related]

  • 26. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Moeini S, Saeidi M, Fotouhi F, Mondanizadeh M, Shirian S, Mohebi A, Gorji A, Ghaemi A.
    Arch Virol; 2017 Feb 05; 162(2):333-346. PubMed ID: 27699512
    [Abstract] [Full Text] [Related]

  • 27. Enhanced anti-tumor effects of HPV16E7(49-57)-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150.
    Chen S, Ou R, Tang J, Deng X, Wu Y, van Velkinburgh JC, Ni B, Xu Y.
    Cancer Epidemiol; 2013 Apr 05; 37(2):172-8. PubMed ID: 23127963
    [Abstract] [Full Text] [Related]

  • 28. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
    Esquerré M, Momot M, Goubier A, Gonindard C, Leung-Theung-Long S, Misseri Y, Bissery MC.
    Vaccine; 2017 Mar 13; 35(11):1509-1516. PubMed ID: 28196735
    [Abstract] [Full Text] [Related]

  • 29. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.
    Diniz MO, Cariri FA, Aps LR, Ferreira LC.
    Hum Gene Ther; 2013 Oct 13; 24(10):861-70. PubMed ID: 24007495
    [Abstract] [Full Text] [Related]

  • 30. Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses.
    Oosterhuis K, Aleyd E, Vrijland K, Schumacher TN, Haanen JB.
    Hum Gene Ther; 2012 Dec 13; 23(12):1301-12. PubMed ID: 22971245
    [Abstract] [Full Text] [Related]

  • 31. A novel "priming-boosting" strategy for immune interventions in cervical cancer.
    Liao S, Zhang W, Hu X, Wang W, Deng D, Wang H, Wang C, Zhou J, Wang S, Zhang H, Ma D.
    Mol Immunol; 2015 Apr 13; 64(2):295-305. PubMed ID: 25575128
    [Abstract] [Full Text] [Related]

  • 32. DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.
    Lin CT, Tsai YC, He L, Yeh CN, Chang TC, Soong YK, Monie A, Hung CF, Lai CH.
    Immunol Lett; 2007 Dec 15; 114(2):86-93. PubMed ID: 17976741
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
    Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC.
    Cancer Res; 2000 Feb 15; 60(4):1035-42. PubMed ID: 10706121
    [Abstract] [Full Text] [Related]

  • 34. MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.
    Saleh T, Bolhassani A, Shojaosadati SA, Aghasadeghi MR.
    Vaccine; 2015 Jun 22; 33(28):3164-70. PubMed ID: 26001433
    [Abstract] [Full Text] [Related]

  • 35. Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors.
    Wang Z, Wei C, Zhang Y, Wang W, Zhou Z, Xiao G.
    Oncol Rep; 2018 Jan 22; 39(1):425-432. PubMed ID: 29115562
    [Abstract] [Full Text] [Related]

  • 36. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
    Huang CY, Chen CA, Lee CN, Chang MC, Su YN, Lin YC, Hsieh CY, Cheng WF.
    Gynecol Oncol; 2007 Dec 22; 107(3):404-12. PubMed ID: 17905417
    [Abstract] [Full Text] [Related]

  • 37. Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines.
    Shahbazi S, Bolhassani A.
    Int Immunopharmacol; 2018 Sep 22; 62():170-180. PubMed ID: 30015237
    [Abstract] [Full Text] [Related]

  • 38. Enhancement of DNA vaccine potency through linkage of antigen gene to ER chaperone molecules, ER-60, tapasin, and calnexin.
    Lin CT, Chang TC, Chao A, Dzeng E, Soong YK, Hung CF, Lai CH.
    J Biomed Sci; 2005 Sep 22; 12(2):279-87. PubMed ID: 15918000
    [Abstract] [Full Text] [Related]

  • 39. Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.
    Kang TH, Monie A, Wu LS, Pang X, Hung CF, Wu TC.
    Vaccine; 2011 Jan 29; 29(5):1082-9. PubMed ID: 21130752
    [Abstract] [Full Text] [Related]

  • 40. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
    Li Y, Subjeck J, Yang G, Repasky E, Wang XY.
    Vaccine; 2006 Jun 19; 24(25):5360-70. PubMed ID: 16714072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.